Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

BPC-157 and Erectile Dysfunction | What Researchers Must Know

Curious about the use of BPC-157 and treat erectile dysfunction? This comprehensive review will provide the most important information available on the application of BPC-157 in the context of erectile dysfunction treatment. We will explain: What is BPC-157 BP

By Recovery & Performance Peptides Editorial Team

Curious about the use of BPC-157 and treat erectile dysfunction?

This comprehensive review will provide the most important information available on the application of BPC-157 in the context of erectile dysfunction treatment.

We will explain:

What is BPC-157

BPC-157 and Erectile Dysfunction

BPC-157 Benefits

BPC-157 Safety

To add, we will offer our expert recommendation for purchasing the best BPC-157 available online.

We detail what must be known about BPC-157, including data from cutting-edge, peer-reviewed studies and how to successfully incorporate this popular peptide into research on erectile dysfunction.

Buy BPC-157 from our top-rated vendor...

Disclaimer: Peptides.org contains information about products that are intended for laboratory and research use only, unless otherwise explicitly stated. This information, including any referenced scientific or clinical research, is made available for educational purposes only. Likewise, any published information relative to the dosing and administration of reference materials is made available strictly for reference and shall not be construed to encourage the self-administration or any human use of said reference materials. Peptides.org makes every effort to ensure that any information it shares complies with national and international standards for clinical trial information and is committed to the timely disclosure of the design and results of all interventional clinical studies for innovative treatments publicly available or that may be made available. However, research is not considered conclusive. Peptides.org makes no claims that any products referenced can cure, treat or prevent any conditions, including any conditions referenced on its website or in print materials.

What is BPC-157?

BPC-157 (Body Protection Compound-157), also known as bepecin, is a synthetic peptide that is evidenced to have a range of therapeutic effects.

A derivative of the naturally occurring gastric protein called Body Protection Compound (BPC), BPC-157 is classed as a pentadecapeptide. BPC is found in the gastrointestinal tract and is vital to digestive function, strengthening and healing lesions in the GI lining. It is also shown to promote angiogenesis, cellular repair, and tissue growth in many organs while modulating inflammatory response [1, 2, 3].

Therapeutic Prospects

BPC-157 is more stable than endogenous BPC and exhibits therapeutic properties without the need for a carrier agent. While the primary action of BPC is in the digestive tract, where it heals and protects the GI lining, BPC-157 is linked in clinical studies to benefits in multiple organ systems. Its systemic effects are primarily attributed to its stimulation of angiogenesis and fibroblast proliferation.

Particular benefits of BPC-157 include improved healing in many types of tissue, such as vascular, hepatic, and nervous. This indicates the peptide’s potential to address symptoms of cardiovascular and neurodegenerative diseases. It is also shown to facilitate regeneration in bone, tendon, and muscle tissues. Lastly, BPC-157 exhibits potent antioxidant properties not just in the GI tract but globally, suggesting its prospective utility in the context of inflammatory disease treatment [2, 3, 4, 5, 6].

Background

BPC-157 was initially synthesized in the early 1990s and studied for its cytoprotective properties as an anti-ulcer agent. Although it entered phase 1 trials in consideration as a treatment of ulcerative colitis, it has not been approved by the US Food and Drug Administration (FDA) for medical use, and data on human subjects is lacking. However, wide research in animal models to date suggests that BPC-157 is safe and well-tolerated when properly administered [1–6].

It is one of the several in-demand research peptides that are prized for their healing and regenerative effects. TB-500 is also similarly under investigation for its angiogenic and reparative properties. Traditionally injected, both TB-500 and BPC-157 have seen recent advances to increase their stability and oral bioavailability, potentially augmenting their therapeutic applications and marketing appeal [7, 8].

Now…let us take a look at what, if anything, BPC-157 peptide can do in cases of erectile dysfunction.

BPC-157 and Erectile Dysfunction

Erectile dysfunction is attributable to several different causes, classified as vasculogenic, psychogenic, endocrinologic, or neurologic. Treatment is typically prescribed according to the underlying cause. However, currently available drugs fall short in some cases, prompting clinicians to search for therapeutic alternatives [9].

Vasculogenic ED

Researchers have long noted the common co-occurrence of ED and cardiovascular or metabolic diseases. Indeed, recent literature advises practitioners to consider ED as an early warning sign of these diseases. Vasculogenic ED in particular is linked with arterial and endothelial damage, often attributed to systemic inflammation.

Among vasculogenic ED patients, traditional ED treatments such as selective PDE5 inhibitors, which act on the penile musculature via the NO system, often fail to elicit long-term therapeutic outcomes in subjects with severe cardiovascular and metabolic disease. Other current treatments such as penile injections function to temporarily increase penile blood flow, a transient solution at best [10, 11, 12].

As such, researchers in the nascent field of regenerative medicine have begun to study alternative ED treatments that consider the roles of angiogenesis, vascular insufficiency, and endothelial dysfunction in the disease. In one study on rat models, cytokine therapy designed to promote angiogenesis and stimulate endothelial growth was proven to effectively treat ED. Another animal study showed that the administration of vascular growth factors led to penile neovascularization, a possible long-term solution to vasculogenic ED [13, 14].

Further novel treatments include lasting modulation through gene therapy of the NO system, which affects penile musculature to enable erectile response. This is considered a favorable alternative to orally bioavailable PDE5 inhibitors that show poor results in subjects with acute metabolic disease [10, 15, 16].

Studies on BPC-157 and Erectile Dysfunction

Despite the ready applicability of BPC-157 in therapeutic contexts such as angiogenesis, endothelial growth, and regulation of the inflammatory response, no studies to date have been specifically conducted on its use in ED patients.

However, the handful of studies available is promising. BPC-157 was shown in rat models to combat heart failure via the NO system, echoing emerging gene therapy modalities in ED treatment. Another study on diabetes-related ED in rats indicated the potential of NO modulation to successfully improve erectile response [10, 17, 18].

Furthering the scope of BPC-157’s potential benefits in ED treatment, it is ripe for synergistic combination with other traditional and emerging treatments. For example, its regenerative and angiogenic effects may aid therapies involving nerve reconstruction and penile transplants of muscle or cartilage tissues. Optimistically, its benefits may preclude the need for surgical intervention altogether. However, barring further research, this remains a speculatory point [11].

In short, BPC-157 shows great promise as a treatment for ED, particularly as a solution to current shortcomings in ED pharmacology regarding vascular etiologies.

BPC-157 Benefits

There is great evidence to support the effects of BPC-157 in various contexts.

While extensive trials in human subjects are lacking, studies to date in both animal and human models are highly favorable. Here is a quick review of the most notable benefits of BPC-157:

Gastrointestinal Health

BPC-157, like its endogenous counterpart, has potent cytoprotective properties, shown to fortify the lining of the GI tract while healing and preventing lesions. As an anti-ulcer agent, it is likely effective in the treatment of inflammatory bowel disease. It is also shown in animal models to bolster biochemical feedback mechanisms along the gut-brain axis [2, 4, 22].

Injury Recovery

The regenerative effects of BPC-157 have been widely documented in animal models, showing improved healing in bone, skin, ligaments, and muscles, among other tissue types. This is attributed to its increase in fibroblast proliferation [3, 22].

Angiogenesis

BPC-157 is further proven in animal studies to prompt vascular growth through increases in endothelial growth factor. This process contributes to injury and wound healing and may greatly benefit cardiovascular health, boosting circulation and normalizing blood pressure. Per the discussion above, this also has implications in the treatment of vasculogenic ED [11, 23, 24].

It must be noted that this can be a double-edged sword, and looking into side effects of BPC-157 is needed.

Neurological Health

With neuroprotective properties, BPC-157 is shown in animal models to reduce damage due to central nervous system injuries and strokes. It is also evidenced to balance neurotransmitter levels, potentially addressing symptoms of Parkinson’s disease, schizophrenia, and depression [2, 6, 11].

Reduces Drug Toxicity

BPC-157 may protect against the toxic effects of certain drugs, such as neuroleptics, alcohol, NSAIDs, and insulin. Protective benefits are evidenced in the liver, GI tract, cardiovascular system, and nervous system [6, 11, 25].

Improved Inflammatory Response

The anti-inflammatory properties of BPC-157 have been well-documented and observable in various tissue types, including the lungs, liver, GI tract, and brain [11, 23].

Emerging investigations indicate that BPC-157 may also aid in collagen synthesis and pain relief [26, 27].

Is BPC-157 Safe?

Due to a lack of clinical trials, there is a shortage of data on the safety of BPC-157 for use in humans. However, research to date suggests a positive safety profile. In humans and animals, it has shown no toxicity and good tolerability [23, 28].

However, researchers should exercise caution in the administration of BPC-157. It is occasionally known to cause transient and mild adverse effects, such as [6]:

Injection site irritation

Nausea

Fatigue

Sweating

Light-headedness

To minimize the risk of adverse effects, researchers are advised to purchase peptides from legitimate suppliers and adhere to established clinical guidelines concerning proper handling.

Where to Buy BPC-157 Online? | 2024 Edition

In light of the exciting potential of BPC-157, it is an excellent addition to clinical research on effective ED treatments.

Yet, it is a must that researchers purchase lab-tested BPC-157 from a legitimate vendor.

As such, the passionate experts at Peptides.org have scoured the net to give readers our top picks for buying premium BPC-157 online:

Limitless Life

Limitless Life is a top vendor that offers lab-tested products, attractive pricing, swift delivery, and unparalleled customer support.

Here’s where they excel:

High-Quality Peptides: All Limitless Life products are third-party lab tested for purity and potency, meaning that their BPC-157 is research-grade. Researchers will find some of the highest quality peptides from this company.

Convenient Payment Options: Limitless Life accepts all major credit cards. In addition, they also offer e-check, Cash App, and cryptocurrency payments. Furthermore, they offer individual and wholesale pricing, should researchers prefer to make bulk purchases.

Fast, Dependable Shipping: Limitless Life delivers peptides to U.S. addresses within 2-3 business days and waives shipping fees on orders over $350. When our team made a test order of BPC-157, it arrived promptly without issues. They also offer affordable shipping insurance.

International Shipping: Limitless Life also offers peptides for international researchers. With many international orders being delivered within a week. A huge benefit to the research community.

Great Service and Support: Limitless Life is one of the few research peptides vendors that offers phone and email support 7-days a week. This makes it easy for researchers to get their questions answered.

On top of that, the team at Peptides.org is impressed with the variety of BPC-157 formulations from Limitless Life. With this peptides vendor, researchers will find lyophilized powder BPC-157, along with other offerings like:

BPC-157 + TB-500 Nasal Spray

BPC-157 Capsules

Lastly, qualified researchers will find a 10% discount on the next order with Limitless Life. Just click the button below and use this code:

peptidesorg10

Xcel Peptides

Why is Xcel Peptides a leading supplier for researchers around the world?

Here's a few reasons:

Third-Party Lab Testing: Xcel Peptides gets every BPC-157 batch tested by an independent lab and posts the lab reports online. This increases transparency and helps build trust.

Great Payment Options: Xcel Peptides offers reliable credit card processing, along with cryptocurrency payments for researchers.

Fast Shipping: As well, Xcel Peptides offers rapid shipping anywhere in the USA. Most orders ship same-day or next day. This means researchers get peptides quickly with this vendor.

Xcel Peptides also offers stable BPC-157 capsules for researchers and a BPC-157 + TB-500 blend.

Buy research peptides from Polaris Peptides today...

Bacteriostatic Water and BPC-157

BPC-157 is often sold as a lyophilized powder that requires reconstitution with a sterile solvent. Scientists tend to agree that bacteriostatic water is the best solvent for this purpose.

What is Bacteriostatic Water?

Composed of sterile water and a natural preservative called benzyl alcohol, bacteriostatic water resists bacterial proliferation to combat contamination. It has an extended shelf life and efficiently dissolves lyophilized peptides while maintaining their purity [19, 20, 21].

Supplies Needed

The correct method of BPC-157 reconstitution calls for the following materials:

Vial of bacteriostatic water

Vial of lyophilized BPC-157

Sterile syringe

Alcohol wipes

Extra sterile vials are recommended

Reconstitution Process

Follow this procedure to reconstitute lyophilized BPC-157 for injection:

Step #1: Wipe all materials with the alcohol swabs to reduce the risk of contamination.

Step #2: Using the sterile syringe, withdraw the desired amount of bac water, typically around 1mL.

Step #3: Slowly inject the bac water into the vial of BPC-157, allowing the powder to gradually dissolve.

Step #4: Refrain from agitating the vial, as this may damage the contents. When the solution is fully mixed, it will appear transparent.

Step #5: The extra solution may be safely refrigerated and accessed for up to 28 days after reconstitution.

Step #6: For precise storage and dosage indications, refer to manufacturer labels.

BPC-157 and Erectile Dysfunction | Verdict

To conclude, BPC-157 shows promise in the treatment of erectile dysfunction as an angiogenic, anti-inflammatory, and healing agent.

It may be particularly suited to combating ED caused by underlying cardiovascular problems. While the research to date certainly indicates great potential, BPC-157 has not yet been closely studied in this context.

Researchers can seize this opportunity to conduct innovative studies into the use of BPC-157 as a novel therapy for symptoms of ED.

To attain top-quality BPC-157, visit our top-recommended vendor.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

BPC-157 Studied Joint Pain: Dosing, Administration, and Research Protocols

Rat Achilles Tendon Transection (2014) Complete tendon rupture 10 mcg/kg daily × 14 days Intraperitoneal injection Tensile strength, histological healing, angiogenesis markers 40% improvement in load-to-failure vs control; increased VEGF expression Most robust evidence for dose-dependent tendon healing. Optimal at lower doses Rat MCL Transection (2016) Complete ligament tear 10 mcg/kg daily × 28 days Collagen fiber density, biomechanical strength 85% pre-injury strength by day 28 vs 60% control Strong structural repair. But intraperitoneal route limits human translation MIA-Induced Arthritis (2021) Cartilage degeneration 10 mcg/kg every other day × 4 weeks Subcutaneous injection Cartilage thickness, MMP levels, pain behaviors Preserved joint space; reduced MMP-3 and MMP-13 expression Suggests protective effect on cartilage but pain measures in rodents are indirect Corticosteroid-Impaired Healing (2018) Iatrogenic tendon damage Intramuscular injection Reversal of corticosteroid-induced weakening Normalized tensile strength despite corticosteroid co-administration Indicates potential as adjunct in steroid-treated populations. Unexplored in humans
STORAGE

Temperature: The Arch-Nemesis of Peptide Stability

We can't stress this enough: temperature is the single most significant factor influencing the rate of BPC-157 degradation reconstituted. It’s the accelerator pedal for nearly every degradation pathway we just mentioned. Think of it this way: chemical reactions, including the ones that break down peptides, happen faster at higher temperatures. Room temperature might feel comfortable to you, but for a reconstituted peptide, it's a hostile environment. Leaving a vial on a lab bench for even a few hours can initiate a cascade of degradation that is completely irreversible. We've seen data showing that some peptides can lose over 50% of their potency within 24 hours at room temperature. That's a catastrophic loss. The entire issue of BPC-157 degradation reconstituted is, in many ways, a battle against thermal energy. This is non-negotiable. Once reconstituted, BPC-157 must be stored in a refrigerator, typically between 2°C and 8°C (36°F and 46°F). This cold environment dramatically slows down molecular motion and the chemical reactions responsible for BPC-157 degradation reconstituted. It doesn't stop them entirely—degradation is an inevitable process—but it slows them to a crawl, preserving the peptide's integrity for weeks instead of hours. Consistently managing temperature is the most powerful tool you have to combat BPC-157 degradation reconstituted and ensure the compound you're studying today is the same as the one you study next week.
02

Question drills

Open a question for its connected answer.

01What If the Pathogen Shows Antibiotic Resistance?+

LL-37's membrane-disruption mechanism remains effective against multidrug-resistant organisms because it doesn't target specific metabolic pathways. Research from the University of British Columbia found LL-37 retained activity against vancomycin-resistant enterococci (VRE) and carbapenem-resistant Enterobacteriaceae (CRE). Pathogens with resistance to last-line antibiotics. Combined with BPC-157 to restore immune function, this dual approach addresses both the pathogen and the compromised host response that allows resistant infections to persist.

SOURCE / realpeptides.co ↗
02What If I Have Diabetic Peripheral Neuropathy — Could BPC-157 Help?+

Consult an endocrinologist before considering any experimental peptide. Diabetic neuropathy develops over years through chronic hyperglycemia-induced oxidative damage. It's not an acute injury like the crush models used in bpc-157 studied neuropathy research. The pathophysiology differs: diabetic nerves face ongoing metabolic stress, not a discrete lesion that can heal. Animal studies showing benefit used streptozotocin-induced diabetes, which mimics Type 1 more than Type 2. No human data exists to guide dosing, duration, or expected outcomes.

SOURCE / realpeptides.co ↗
03What If Research-Grade BPC-157 Contains Impurities That Affect Efficacy or Safety?+

BPC-157 is not FDA-approved, so no pharmaceutical-grade formulation exists under Good Manufacturing Practice (GMP) oversight. Research suppliers operate without the batch-to-batch purity verification, endotoxin testing, or sterility guarantees required for injectable drugs. A 2022 analysis published in Drug Testing and Analysis tested 11 commercial BPC-157 products and found purity ranging from 68% to 94%. The remainder being degradation products, synthesis byproducts, or unidentified peptide fragments. Impurities can trigger immune reactions, alter bioavailability, or introduce contamination risk that wouldn't exist with pharmaceutical-grade compounds.

SOURCE / realpeptides.co ↗
04What If the Healing Timeline Extends Beyond the Expected 8–12 Weeks?+

Extended timelines are common in subjects over 60, particularly in avascular tissue (tendons, ligaments). If progress plateaus after 12 weeks at 200–250mcg, the issue is rarely peptide dose. It's mechanical loading. Controlled resistance exercise or eccentric loading is required to signal collagen remodelling. BPC-157 supports angiogenesis and cellular migration, but it doesn't replace the mechanical stimulus required for structural tissue organisation.

SOURCE / realpeptides.co ↗
05Frequently asked questions (FAQs)+

Are you curious to know more? We’ve compiled a list of common BPC-157 questions and their answers.

SOURCE / livvnatural.com ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Research in BPC-157 Peptide

BPC, being a naturally occurring element in the body, has been suggested, in various research studies on animal models, the potential to enhance tissue repairing processes. Its potential efficacy extends beyond intestinal repair, showcasing similar reparative outcomes in various body tissues. Studies on the healing mechanisms of BPC-157 suggest an association, to some extent, with Growth Hormone. In terms of fibroblast activity, research findings propose that BPC-157 peptide concentrations may impact the relocation of fibroblasts, potentially prompting the migration of more fibroblasts with elevated BPC levels. Earlier studies have hinted at BPC-157’s role in managing collagen fragments, affecting Fibroblasts’ function and influencing the deposition and maintenance of collagen. Scientific data indicates that BPC-157 may significantly accelerate fibroblasts’ migration, potentially leading to a threefold increase in fibroblast reproduction following exposure. Regarding tendon healing, studies suggest that BPC-157 contributes to the enhanced recovery of transversely cut rodents’ Achilles tendons, restoring the entire integrity of the tendon. Similar effects were observed in the case of ligament injuries in rodents, with injuries healing within three months of surgical intervention after exposure to BPC-157. Research findings also propose that BPC-157 may potentiate a positive impact on brain healing, particularly in cases of inflammation, hemorrhage, and edema, as well as traumatic brain damage and severe brain pathologies resulting from gastrointestinal/liver lesions or insulin and NSAID overdose. BPC-157’s speculated benefits extend to aiding in the healing of blood vessel damage, showcasing potential for angiogenesis (the formation of new blood vessels) and inhibiting and reversing the formation of blood clots due to abdominal aorta anastomosis. Research suggests that BPC-157 acquires significant healing properties in various tissues such as skeletal muscles, bones, tendons, and ligaments. Additionally, they propose that BPC-157 might play a role as a promoter or modifier of the body’s natural healing system. In speculative terms, BPC-157 peptide is associated with various physiological action, including bone healing, repairing skin damage, muscle injury, and healing the sciatic nerve. Disclaimer: The products mentioned are not intended for human or animal consumption. Research chemicals are intended solely for laboratory experimentation and/or in-vitro testing. Bodily introduction of any sort is strictly prohibited by law. All purchases are limited to licensed researchers and/or qualified professionals. All information shared in this article is for educational purposes only.

RESEARCH

Ischaemia-Reperfusion Injury Research

BPC-157 cardioprotection in I/R injury models extends its established cytoprotective biology from gastric and musculoskeletal tissues to the heart. In vivo LAD ligation I/R models (30-minute ischaemia/120-minute reperfusion) with BPC-157 pre-treatment or treatment at reperfusion test: infarct size (TTC/risk area ratio), serum troponin I release, cardiac function (echocardiography EF/FS, invasive dP/dt), and histological cardiomyocyte damage. The mechanistic basis may parallel BPC-157’s established cytoprotective signalling: PI3K/Akt activation reducing apoptosis through BAD phosphorylation and cytochrome c release suppression; eNOS-derived NO reducing platelet activation and coronary vasospasm at reperfusion; and anti-inflammatory NF-κB suppression reducing neutrophil-mediated reperfusion injury. BPC-157 research in cardiac I/R models is mechanistically contrasted with hexarelin and GHRP-6, which operate through GHS-R1a-RISK pathway mechanisms — a distinct receptor and signalling pathway. This comparison allows interrogation of whether converging on similar downstream endpoints (Akt activation, mPTP resistance, anti-apoptosis) through different upstream receptors produces additive cardioprotection — a combination research question in preclinical cardiovascular biology.

05

Product & matchup locker

Linked catalog and comparison files.

Comparison

Local Versus Systemic Injection

For specific injuries, injecting 1 to 2 inches from the injury site delivers high local concentration while still providing systemic benefits. For vagal and neurological effects, …

Comparison

Comparison with Other Tissue-Repair Peptides in Immune Biology

Relative to TB-500 (Thymosin Beta-4, also a tissue repair peptide with immune effects): both BPC-157 and TB-500 suppress NF-κB-driven cytokine production in macrophages, but throu…

Comparison

Comparison with Other Research Peptides

Compared to peptides like CJC-1295 and Tesamorelin, BPC-157 exhibits a distinct profile focused on tissue regeneration and angiogenesis rather than growth hormone stimulation. Whi…

Continue reading

Related articles